| 标题 |
[求助补充材料]
Safety, tolerability, pharmacokinetics, and pharmacodynamics of the first-in-class GLP-1 and amylin receptor agonist, amycretin: a first-in-human, phase 1, double-blind, randomised, placebo-controlled trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet 作者:A. Gasiorek; Arne Heydorn; S. Gabery; Julie B. Hjerpsted; Katrine Kirkeby; et al 出版日期:2025-06-01 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)